Literature DB >> 21980204

Thrombolytic therapy rates and stroke severity: an analysis of data from the Swedish stroke register (Riks-Stroke) 2007-2010.

Anna Stecksén1, Kjell Asplund, Peter Appelros, Eva-Lotta Glader, Bo Norrving, Marie Eriksson.   

Abstract

BACKGROUND AND
PURPOSE: We tested the hypothesis that higher proportions of patients with minor stroke being treated with thrombolysis contribute to increasing overall rates of thrombolysis.
METHODS: We included 1743 ischemic stroke patients (age 18-80 years) treated with thrombolysis, recorded in the Swedish stroke register Riks-Stroke between 2007 and 2010. Minor stroke was defined as National Institutes of Health Stroke Scale score ≤ 5.
RESULTS: The proportion with minor stroke among patients treated with thrombolysis increased from 22.1% in 2007 to 28.7% in 2010 (P=0.021). The rate of increase did not differ significantly between men and women, age groups, or hospital types (university hospitals, other large hospitals, or community hospitals). Hospitals with high proportions of thrombolysis patients with minor stroke were more likely to have high thrombolysis frequencies (R=0.55; P<0.001).
CONCLUSIONS: In recent years, an increase in the proportion of patients with minor stroke treated with thrombolysis has contributed to rising overall thrombolysis rates in Sweden. At the hospital level, high rates of thrombolysis are associated with a high proportion of minor stroke being treated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21980204     DOI: 10.1161/STROKEAHA.111.630590

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

Review 1.  Intravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview.

Authors:  Qiang Huang; Qingfeng Ma; Jianping Jia; Jian Wu
Journal:  Neurol Sci       Date:  2014-07-26       Impact factor: 3.307

2.  Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability.

Authors:  Pei-Hsun Sung; Hung-Sheng Lin; Wei-Che Lin; Chiung-Chih Chang; Sung-Nan Pei; Ming-Chun Ma; Kuan-Hung Chen; John Y Chiang; Hsueh-Wen Chang; Fan-Yen Lee; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

3.  ABCD² score may discriminate minor stroke from TIA on patient admission.

Authors:  Hui Zhao; Qingjie Li; Mengru Lu; Yuan Shao; Jingwei Li; Yun Xu
Journal:  Transl Stroke Res       Date:  2013-10-17       Impact factor: 6.829

4.  Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.

Authors:  Negar Asdaghi; Kefeng Wang; Maria A Ciliberti-Vargas; Carolina Marinovic Gutierrez; Sebastian Koch; Hannah Gardener; Chuanhui Dong; David Z Rose; Enid J Garcia; W Scott Burgin; Juan Carlos Zevallos; Tatjana Rundek; Ralph L Sacco; Jose G Romano
Journal:  Stroke       Date:  2018-02-19       Impact factor: 7.914

5.  Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial.

Authors:  Tzu-Hsien Tsai; Cheng-Hsien Lu; Christopher Glenn Wallace; Wen-Neng Chang; Shu-Feng Chen; Chi-Ren Huang; Nai-Wen Tsai; Min-Yu Lan; Pei-Hsun Sung; Chu-Feng Liu; Hon-Kan Yip
Journal:  Crit Care       Date:  2015-02-25       Impact factor: 9.097

6.  Safety and outcome of thrombolysis in mild stroke: a meta-analysis.

Authors:  Lei Shi; Min Zhang; Hengfang Liu; Bo Song; Changdong Song; Dandan Song; Yuming Xu
Journal:  Med Sci Monit       Date:  2014-11-02

7.  Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke.

Authors:  Kuan-Hung Chen; Chih-Hung Chen; Christopher Glenn Wallace; Chun-Man Yuen; Gour-Shenq Kao; Yi-Ling Chen; Pei-Lin Shao; Yung-Lung Chen; Han-Tan Chai; Kun-Chen Lin; Chu-Feng Liu; Hsueh-Wen Chang; Mel S Lee; Hon-Kan Yip
Journal:  Oncotarget       Date:  2016-11-15

Review 8.  Recent advances in the management of acute ischemic stroke.

Authors:  Philip Chang; Shyam Prabhakaran
Journal:  F1000Res       Date:  2017-04-13

9.  Higher neutrophil counts and neutrophil-to-lymphocyte ratio predict prognostic outcomes in patients after non-atrial fibrillation-caused ischemic stroke.

Authors:  Yen-Nan Fang; Meng-Shen Tong; Pei-Hsun Sung; Yung-Lung Chen; Chih-Hung Chen; Nei-Wen Tsai; Chih-Jen Huang; Ya-Ting Chang; Shu-Fang Chen; Wen-Neng Chang; Cheng-Hsien Lu; Hon-Kan Yip
Journal:  Biomed J       Date:  2017-05-30       Impact factor: 4.910

10.  Nationwide temporal trend analysis of reperfusion therapy utilization and mortality in acute ischemic stroke patients in Japan.

Authors:  Megumi Maeda; Haruhisa Fukuda; Ryu Matsuo; Fumi Kiyuna; Tetsuro Ago; Takanari Kitazono; Masahiro Kamouchi
Journal:  Medicine (Baltimore)       Date:  2021-01-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.